|
Market Closed -
Other stock markets
|
After hours 21:36:58 | |||
| 1.550 EUR | +1.04% |
|
1.569 | +1.23% |
| 05-15 | Innate Pharma soars following reassuring quarterly update on clinical pipeline |  |
| 05-13 | Innate Pharma S.A., Q1 2026 Earnings Call, May 13, 2026 |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| - | |||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Stocks
- IPH Stock
- Consensus Innate Pharma
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
